121 filings
Page 5 of 7
8-K
hsp6cq5h4p wk0
6 Aug 15
Regulation FD Disclosure
12:00am
8-K
t2a66g849ps8iet6tgl5
6 Aug 15
Regulation FD Disclosure
12:00am
UPLOAD
4eiunfo2tto
6 Aug 15
Letter from SEC
12:00am
UPLOAD
ir5ku
19 Jun 15
Letter from SEC
12:00am
8-K
popf6
11 May 15
Regulation FD Disclosure
12:00am
8-K
iooysx7mby
22 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
m3xp1rgjpa9zqltv0m
18 Mar 15
Other Events
12:00am
8-A12B
n9oduje
17 Mar 15
Registration of securities on exchange
12:00am
8-K
jk7j1ier
16 Mar 15
European Commission Clears Actavis’ Pending Acquisition of Allergan
12:00am
8-K
mev5193jk
13 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
1204j8a
12 Mar 15
Actavis Announces Closing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
12:00am
8-K
ba0jbia
10 Mar 15
Actavis and Allergan Shareholders Approve Proposals
12:00am
8-K
e9uh0597c
6 Mar 15
Entry into a Material Definitive Agreement
12:00am
424B2
l1bmqcs1m49g nz9pc
5 Mar 15
Prospectus for primary offering
12:00am
8-K
21epqkuslbt
4 Mar 15
Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
12:00am
424B5
qf19cd6i v6dbbja3
2 Mar 15
Prospectus supplement for primary offering
12:00am
8-K
pgrw7hr
2 Mar 15
Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
12:00am
8-K
ncute0k3rbpyvg
2 Mar 15
Entry into a Material Definitive Agreement
12:00am